1. Home
  2. STEX vs ALGS Comparison

STEX vs ALGS Comparison

Compare STEX & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Streamex Corp.

STEX

Streamex Corp.

SELL

Current Price

$0.31

Market Cap

38.0M

Sector

N/A

ML Signal

SELL

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$1.27

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEX
ALGS
Founded
2009
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.0M
34.6M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
STEX
ALGS
Price
$0.31
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $36.88
AVG Volume (30 Days)
★ 979.1K
69.7K
Earning Date
11-12-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 88.30
EPS
★ N/A
N/A
Revenue
$18,000.00
★ $2,186,000.00
Revenue This Year
N/A
$1,433.30
Revenue Next Year
$1,314.29
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.26
$1.22
52 Week High
$4.76
$13.69

Technical Indicators

Market Signals
Indicator
STEX
ALGS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
STEX
ALGS

About STEX Streamex Corp.

Streamex Corp is a vertically integrated technology and infrastructure company. The Company is a technology company with two principal lines of business: (i) Tokenized Asset Finance, focused on digital asset and real-world asset tokenization via Streamex Exchange platform, and (ii) Biomedical Technology, focused on signal processing solutions in electrophysiology. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: